Vendevia Group

Kurt R. Gehlsen, Ph.D.

Vice President and Chief Scientific Officer, Research Corporation Technologies

 

As CSO of RTC, Dr. Gehlsen provides scientific leadership in the review and oversight of their biomedical investment activities. He works closely with the company's technology identification, development and business functions. Dr. Gehlsen has 20 years experience working in private and public companies, pharmaceutical product development, basic research, clinical development, regulatory affairs, strategic planning, business development, investor relations and executive management.

Biomedical Venture Development

Boris Reznik, PhD

Chairman

 

Thomas Ichim, PhD

Managing Partner

 

Gary Reznik, MD

Managing Partner

 

Helen Picone, CPA

CFO and Controller

 

Paul Butler, Esq.

Advisory Board

 

Kurt Gehlsen, PhD,

Advisory Board

 

Eugene Golub,

Advisory Board

 

Russel Kaufman, MD,

Advisory Board

 

Robert Pearlman

Advisory Board